Kidney Transplant Recipients Rarely Show an Early Antibody Response Following the First COVID-19 Vaccine Administration

Stephanie G Yi^{1

2}, Richard J Knight^{1

2}, Edward A Graviss^{1

3}, Linda W Moore¹, Duc T Nguyen³, R Mark Ghobrial^{1

2}, A Osama Gaber^{1

2}, Howard J Huang^{2

4}

Affiliations

¹ Department of Surgery, Houston Methodist Hospital, Houston, TX.
² J.C. Walter Jr. Center for Transplantation, Houston Methodist Hospital, Houston, TX.
³ Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX.
⁴ Division of Pulmonology, Department of Internal Medicine, Houston Methodist Hospital, Houston, TX.

Stephanie G Yi et al. Transplantation. 2021.

. 2021 Jul 1;105(7):e72-e73.

doi: 10.1097/TP.0000000000003764.

Stephanie G Yi^{1

2}, Richard J Knight^{1

2}, Edward A Graviss^{1

3}, Linda W Moore¹, Duc T Nguyen³, R Mark Ghobrial^{1

2}, A Osama Gaber^{1

2}, Howard J Huang^{2

4}

¹ Department of Surgery, Houston Methodist Hospital, Houston, TX.
² J.C. Walter Jr. Center for Transplantation, Houston Methodist Hospital, Houston, TX.
³ Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX.
⁴ Division of Pulmonology, Department of Internal Medicine, Houston Methodist Hospital, Houston, TX.

No abstract available

Conflict of interest statement

The authors declare no funding or conflicts of interest.

1. Walsh EE, Frenck RW Jr, Falsey AR, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med. 2020; 383:2439–2450
1. Chavarot N, Leruez-Ville M, Scemla A, et al. Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection. Kidney Int. 2021; 99:486–488